Use of heart failure medications in older individuals and associations with cognitive impairment

Linnea Abramsson1, Annica Backman2, Hugo Lövheim3,4

  • 1Department of Integrative Medical Biology, Umeå University, Umeå, 901 87, Sweden.

BMC Geriatrics
|August 29, 2023
PubMed

Insights

Older adults with cognitive impairment receive fewer heart failure prescriptions. Achieving target medication doses remains a challenge for many older individuals, indicating a need for optimized heart failure treatment.

Area of Science:

  • Gerontology
  • Cardiology
  • Pharmacology

Background:

  • Optimal heart failure treatment requires adherence to recommended drug regimens at target doses.
  • Cognitive impairment can lead to underuse of essential medications.
  • Investigating medication use in older adults with and without cognitive impairment is crucial for understanding treatment gaps.

Purpose of the Study:

  • To compare filled prescriptions and target doses of heart failure medications in older individuals with and without cognitive impairment.
  • To identify factors associated with medication underuse and suboptimal dosing in this population.

Main Methods:

  • Utilized two Swedish datasets: nursing home residents linked to national registers and medical records of older hospital patients.
  • Analyzed filled prescriptions for mineralocorticoid receptor antagonists, loop diuretics, and beta blockers.
  • Evaluated achievement of target doses for heart failure medications in home-dwelling individuals aged 75+.

Main Results:

  • Individuals without cognitive impairment had significantly more filled prescriptions for mineralocorticoid receptor antagonists and loop diuretics.
  • No significant differences were found in achieving target doses between cognitively impaired and non-impaired groups.
  • Advanced age correlated with fewer filled prescriptions and lower achievement of target doses for beta blockers.

Conclusions:

  • Cognitive impairment is associated with undertreatment of heart failure due to fewer filled prescriptions for key medications.
  • A substantial proportion of older adults do not reach target medication doses, highlighting opportunities for optimizing heart failure management.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
463
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
13
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
364
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
91
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19